OSTEONIC Co., Ltd. (KOSDAQ:226400)
South Korea
· Delayed Price · Currency is KRW 6,330.00
-60.00 (-0.94%)
At close: Dec 5, 2025
OSTEONIC Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Operating Revenue | 42,114 | 34,235 | 27,799 | 19,839 | 15,598 |
| Other Revenue | - | - | - | -0 | -0 |
| Revenue | 42,114 | 34,235 | 27,799 | 19,839 | 15,598 |
| Revenue Growth (YoY) | 29.41% | 23.15% | 40.12% | 27.19% | - |
| Cost of Revenue | 21,182 | 17,575 | 14,838 | 11,195 | 9,151 |
| Gross Profit | 20,932 | 16,660 | 12,960 | 8,644 | 6,446 |
| Selling, General & Admin | 8,772 | 8,098 | 6,950 | 5,690 | 4,403 |
| Research & Development | 2,884 | 1,562 | 1,254 | 454.15 | 255.78 |
| Amortization of Goodwill & Intangibles | 143.95 | 138.06 | 47.09 | 50.5 | 38.72 |
| Other Operating Expenses | 168.27 | 149.46 | 99.19 | 172.76 | 136.06 |
| Operating Expenses | 14,833 | 9,774 | 8,118 | 6,118 | 5,867 |
| Operating Income | 6,099 | 6,886 | 4,843 | 2,526 | 579.41 |
| Interest Expense | -1,200 | -970.47 | -756.43 | -1,373 | -1,606 |
| Interest & Investment Income | 290.89 | 337.85 | 369.62 | 213.85 | 151.64 |
| Currency Exchange Gain (Loss) | 976.53 | 1,767 | 199.59 | 757.69 | 789.97 |
| Other Non Operating Income (Expenses) | 1,995 | -1,497 | -2,370 | 1,970 | -4,528 |
| EBT Excluding Unusual Items | 8,161 | 6,523 | 2,285 | 4,094 | -4,614 |
| Gain (Loss) on Sale of Investments | 363.8 | 167.5 | -8.84 | -622.33 | -244.81 |
| Gain (Loss) on Sale of Assets | 8.85 | 4.85 | 1.33 | 4.72 | -65.24 |
| Asset Writedown | -56.43 | -56.43 | -496.63 | -1,373 | -513.88 |
| Other Unusual Items | - | - | - | -22.42 | - |
| Pretax Income | 8,477 | 6,639 | 1,781 | 2,081 | -5,438 |
| Income Tax Expense | 1,976 | 989.21 | -1,877 | 1,245 | -2,586 |
| Net Income | 6,501 | 5,650 | 3,658 | 835.53 | -2,852 |
| Net Income to Common | 6,501 | 5,650 | 3,658 | 835.53 | -2,852 |
| Net Income Growth | 5.17% | 54.46% | 337.77% | - | - |
| Shares Outstanding (Basic) | 20 | 20 | 19 | 17 | 16 |
| Shares Outstanding (Diluted) | 20 | 20 | 19 | 21 | 16 |
| Shares Change (YoY) | 0.24% | 4.00% | -10.88% | 37.15% | - |
| EPS (Basic) | 325.57 | 285.31 | 193.12 | 49.94 | -182.75 |
| EPS (Diluted) | 324.34 | 285.00 | 192.00 | 4.67 | -183.00 |
| EPS Growth | 4.66% | 48.44% | 4008.00% | - | - |
| Free Cash Flow | -2,555 | -453.42 | -1,968 | 3,504 | 2,006 |
| Free Cash Flow Per Share | -127.67 | -22.86 | -103.17 | 163.72 | 128.57 |
| Gross Margin | 49.70% | 48.66% | 46.62% | 43.57% | 41.33% |
| Operating Margin | 14.48% | 20.11% | 17.42% | 12.73% | 3.72% |
| Profit Margin | 15.44% | 16.50% | 13.16% | 4.21% | -18.28% |
| Free Cash Flow Margin | -6.07% | -1.32% | -7.08% | 17.66% | 12.86% |
| EBITDA | 9,765 | 10,304 | 7,550 | 4,942 | 2,793 |
| EBITDA Margin | 23.19% | 30.10% | 27.16% | 24.91% | 17.90% |
| D&A For EBITDA | 3,666 | 3,419 | 2,707 | 2,415 | 2,213 |
| EBIT | 6,099 | 6,886 | 4,843 | 2,526 | 579.41 |
| EBIT Margin | 14.48% | 20.11% | 17.42% | 12.73% | 3.72% |
| Effective Tax Rate | 23.31% | 14.90% | - | 59.85% | - |
| Advertising Expenses | - | 520.44 | 422.53 | 288.76 | 154.13 |
Source: S&P Capital IQ. Standard template. Financial Sources.